Cochrane Abstracts
Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Continuous Glucose Monitoring Systems for Monitoring Cystic Fibrosis‐related Diabetes." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432761/all/Escitalopram_versus_other_antidepressive_agents_for_depression_Edited__no_change_to_conclusions_. Accessed 11 December 2023.
Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432761/all/Escitalopram_versus_other_antidepressive_agents_for_depression_Edited__no_change_to_conclusions_. Accessed December 11, 2023.
Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432761/all/Escitalopram_versus_other_antidepressive_agents_for_depression_Edited__no_change_to_conclusions_
Continuous Glucose Monitoring Systems for Monitoring Cystic Fibrosis‐related Diabetes [Internet]. In: Cochrane Abstracts. [cited 2023 December 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432761/all/Escitalopram_versus_other_antidepressive_agents_for_depression_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes
ID - 432761
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432761/all/Escitalopram_versus_other_antidepressive_agents_for_depression_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
